Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
RecruitingNCT04560673Phase: PHASE2Started 2020-07-10
Summary
This phase II trial investigates how well duloxetine and neurofeedback training work in treating patients with chemotherapy induced peripheral neuropathy. Duloxetine is a type of serotonin and norepin
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Harris Health System (LBJ)Houston, Texas, United States
M D Anderson Cancer CenterHouston, Texas, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT04560673